Effect of procathepsin D activation peptide on gene expression of breast cancer cells

Cancer Letters

Volumn 239, Issue 1, 2006, Pages 46-54

  Benes, Petr ^a   Vashishta, Aruna ^b   Saraswat Ohri, Sujata ^b   Fusek, Martin ^c   Pospisilova, Sarka ^d   Tichy, Boris ^d   Vetvicka, Vaclav ^b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b University of Louisville School of Medicine   (United States)

^c INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Breast cancer; Gene expression; Microarray analysis; Procathepsin D

Indexed keywords

CATHEPSIN D; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CANCER THERAPY; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; MICROARRAY ANALYSIS; MITOGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BREAST NEOPLASMS; CATHEPSIN D; ENZYME PRECURSORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NF-KAPPA B P52 SUBUNIT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 33745367661     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.07.030     Document Type: Article

References (45)

1. Vetvicka V., Vetvickova J., and Benes P. Role of enzymatically inactive procathepsin D in lung cancer. Anticancer Res. 24 (2004) 2739-2744
2. Vetvicka V., Benes P., and Fusek M. Procathepsin D in breast cancer: what do we know? effects of ribozymes and other inhibitors. Cancer Gene Ther. 9 (2002) 854-863
3. Vashishta A., Fusek M., and Vetvicka V. Possible role of procathepsin D in human cancer. Folia Microbiol. 50 (2005) 71-76
4. Rochefort H. Cathepsin D in breast cancer: a tissue marker associated with metastasis. Eur. J. Cancer 28 (1992) 1780-1783
5. Rochefort H., and Liaudet-Coopman E. Cathepsin D in cancer metastasis: a protease and a ligand. APMIS 107 (1999) 86-95
6. Brouillet J.P., Dufour F., Lemamy G., Garcia M., Schlup N., Grenier J., et al. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay. Cancer 79 (1997) 2132-2136
7. Fusek M., and Vetvicka V. Mitogenic function of human procathepsin D: the role of the propeptide. Biochem. J. 303 (1994) 775-780
8. Vetvicka V., Vetvickova J., and Fusek M. Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development. Breast Cancer Res. Treat. 57 (1999) 261-269
9. Glondu M., Liaudet-Coopman E., Derocq D., Platet N., Rochefort H., and Garcia M. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene 21 (2002) 5127-5134
10. Berchem G., Glondu M., Gleizes M., Brouillet J.P., Vignon F., Garcia M., and Liaudet-Coopman E. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 21 (2002) 5951-5955
11. Glondu M., Coopman P., Laurent-Matha V., Garcia M., Rochefort H., and Liaudet-Coopman E. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene 20 (2001) 6920-6929
12. Vetvicka V., Vetvickova J., and Fusek M. Role of procathepsin D activation peptide in prostate cancer growth. Prostate 44 (2000) 1-7
13. Ravi R., and Bedi A. NF-kappaB in cancer-a friend turned foe. Drug Resist. Updat. 7 (2004) 53-67
14. Joyce D., Albanese C., Steer J., Fu M., Bouzahzah B., and Pestell R.G. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 12 (2001) 73-90
15. Burstein E., and Duckett C.S. Dying for NF-kappaB? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr. Opin. Cell Biol. 15 (2003) 732-737
16. Bours V., Bentires-Alj M., Hellin A.C., Viatour P., Robe P., Delhalle S., et al. Nuclear factor-kappa B, cancer, and apoptosis. Biochem. Pharmacol. 60 (2000) 1085-1089
17. Hacker H., and Karin M. Is NF-kappaB2/p100 a direct activator of programmed cell death?. Cancer Cell 2 (2002) 431-433
18. Amit S., and Ben-Neriah Y. NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Semin. Cancer Biol. 13 (2003) 15-28
19. Dejardin E., Bonizzi G., Bellahcene A., Castronovo V., Merville M.P., and Bours V. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene 11 (1995) 1835-1841
20. Cogswell P.C., Guttridge D.C., Funkhouser W.K., and Baldwin Jr. A.S. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19 (2000) 1123-1131
21. Schmitz A.A., Govek E.E., Bottner B., and Van Aelst L. Rho GTPases: signaling, migration, and invasion. Exp. Cell Res. 261 (2000) 1-12
22. Erickson J.W., and Cerione R.A. Multiple roles for Cdc42 in cell regulation. Curr. Opin. Cell Biol. 13 (2001) 153-157
23. Fritz G., Brachetti C., Bahlmann F., Schmidt M., and Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br. J. Cancer 87 (2002) 635-644
24. Fritz G., Just I., and Kaina B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81 (1999) 682-687
25. Bouzahzah B., Albanese C., Ahmed F., Pixley F., Lisanti M.P., Segall J.D., et al. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol. Med. 7 (2001) 816-830
26. Nilsson I., and Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res. 4 (2000) 107-114
27. Chua S.S., Ma Z., Ngan E., and Tsai S.Y. Cdc25B as a steroid receptor coactivator. Vitam. Horm. 68 (2004) 231-256
28. Ngan E.S., Hashimoto Y., Ma Z.Q., Tsai M.J., and Tsai S.Y. Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene 22 (2003) 734-739
29. Kudo Y., Yasui W., Ue T., Yamamoto S., Yokozaki H., Nikai H., and Tahara E. Overexpression of cyclin-dependent kinase-activating Cdc25B phosphatase in human gastric carcinomas. Jpn. J. Cancer Res. 88 (1997) 947-952
30. Sasaki H., Yukiue H., Kobayashi Y., Tanahashi M., Moriyama S., Nakashima Y., et al. Expression of the Cdc25B gene as a prognosis marker in non-small cell lung cancer. Cancer Lett. 173 (2001) 187-192
31. Ito Y., Yoshida H., Uruno T., Takamura Y., Miya A., Kuma K., and Miyauchi A. Expression of Cdc25A and Cdc25B phosphatase in breast carcinoma. Breast Cancer 11 (2004) 295-300
32. Saoncella S., Echtermeyer F., Denhez F., Nowlen J.K., Mosher D.F., Robinson S.D., et al. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc. Natl. Acad. Sci. USA 96 (1999) 2805-2810
33. Couchman J.R., and Woods A. Syndecan-4 and integrins: combinatorial signaling in cell adhesion. J. Cell Sci. 112 (1999) 3415-3420
34. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella S., Denhez F., Detmar M., and Goetinck P.F. Delayed wound repairand impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107 (2001) R9-R14
35. Feistritzer C., Kaneider N.C., Sturn D.H., and Wiedermann C.J. Syndecan-4-dependent migration of human eosinophils. Clin. Exp. Allergy 34 (2004) 696-703
36. Landry R., Rioux V., and Bensadoun A. Characterization of syndecan-4 expression in 3T3-F442A mouse adipocytes: link between syndecan-4 induction and cell proliferation. Cell Growth Differ. 12 (2001) 497-504
37. Berdowska I. Cysteine proteases as disease markers. Clin. Chim. Acta 342 (2004) 41-69
38. Yan S., Sameni M., and Sloane B.F. Cathepsin B and human tumor progression. Biol. Chem. 379 (1998) 113-123
39. Duffy M.J. Proteases as prognostic markers in cancer. Clin. Cancer Res. 2 (1996) 613-618
40. Flaherty D.M., Monick M.M., and Hunninghake G.W. AP endonucleases and the many functions of Ref-1. Am. J. Respir. Cell Mol. Biol. 25 (2001) 664-667
41. Evans A.R., Limp-Foster M., and Kelley M.R. Going APE over ref-1. Mutat. Res. 461 (2000) 83-108
42. Laurent-Matha V., Maruani-Herrmann S., Prebois C., Beaujouin M., Glondu M., Noel A., et al. Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J. Cell. Biol. 168 (2005) 489-499
43. Liptay S., Schmid R.M., Nabel E.G., and Nabel G.J. Transcriptional regulation of NF-kappa B2: evidence for kappa B-mediated positive and negative autoregulation. Mol. Cell. Biol. 14 (1994) 7695-7703
44. Arozarena I., Aaronson D.S., Matallanas D., Sanz V., Ajenjo N., Tenbaum S.P., et al. The Rho family GTPase Cdc42 regulates the activation of Ras/MAP kinase by the exchange factor Ras-GRF. J. Biol. Chem. 275 (2000) 26441-26448
45. Rochefort H., Glondu M., Sahla M.E., Platet N., and Garcia M. How to target estrogen receptor-negative breast cancer?. Endocr. Relat. Cancer 10 (2003) 261-266